StockStory.org on MSN

Eli Lilly (NYSE:LLY) Delivers Strong Q3 Numbers, Stock Soars

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion.

Eli Lilly (LLY) To Report Earnings Tomorrow: Here Is What To Expect

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be announcing earnings results this Thursday before market open. Here ...
24/7 Wall St.

Eli Lilly Blows Away Q3 Earnings Expectations

The Big Pharma mainstay blew away EPS and revenue expectations when it reported Q3 financials, with management raising ...

Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings

Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares ...

Eli Lilly: Is Another Monster Quarter Coming

October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound ...